Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy of treating locally advanced pancreatic cancer using
Stereotactic Body Radiotherapy (using Trilogy) and Gemcitabine